-
Something wrong with this record ?
Pigmented Hypertrichosis with Insulin-Dependent Diabetes Mellitus Syndrome: A Case Series
A. Jacobs, P. Cifelli, D. Delbeck, N. Elbarbary, E. Gevers, Z. Sumnik, SA. Amaratunga, A. Pundziute Lyckå, K. Casteels, SWEET and DPV study group
Language English Country Switzerland
Document type Case Reports, Journal Article
PubMed
38163427
DOI
10.1159/000536019
Knihovny.cz E-resources
- MeSH
- Autoantibodies blood immunology MeSH
- Diabetes Mellitus, Type 1 * genetics complications MeSH
- Child MeSH
- Hypertrichosis * genetics MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Mutation MeSH
- Consanguinity MeSH
- Child, Preschool MeSH
- Nucleoside Transport Proteins genetics MeSH
- Syndrome MeSH
- Check Tag
- Child MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
INTRODUCTION: Pigmented hypertrichosis with insulin-dependent diabetes mellitus (PHID) syndrome is a rare disease, and part of the cluster histiocytosis-lymphadenopathy plus syndrome (H syndrome), which is associated with mutations in the SLC29A3 gene. Patients with PHID show clinical features of H syndrome but also have insulin-dependent diabetes mellitus. The PHID has previously been described as predominantly in absence of pancreatic autoantibodies. Case Series Presentation: Through an open call in two international diabetes registers, clinical and genetic characteristics of 7 PHID patients in 6 treatment centres were collected after informed consent. All of them had consanguinity in their families, and their origins were located in North-African and Middle Eastern regions. Four out of 7 patients had at least one positive pancreatic autoantibody. DISCUSSION AND CONCLUSION: Our case series reveals that PHID exhibits a wide range of clinical symptoms and signs. When consanguinity is present in a patient with newly diagnosed diabetes, and/or if other atypical symptoms such as dysmorphic features, skin lesions, haematological abnormalities, and developmental delay are present, threshold for genetic analysis should be low. Moreover, the presence of autoantibodies should not withhold genetic testing as our case series contradicts the previous observation of predominant autoantibody absence in PHID.
Centre for Endocrinology Queen Mary University of London London UK
Department for Paediatrics Whipps Cross Hospital Barts Health NHS Trust London UK
Department of Development and Regeneration KU Leuven Leuven Belgium
Department of Paediatric Endocrinology and Diabetes University hospital Leuven Leuven Belgium
Department of Paediatrics Helios Klinikum Krefeld Krefeld Germany
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25010537
- 003
- CZ-PrNML
- 005
- 20250429135202.0
- 007
- ta
- 008
- 250415s2025 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000536019 $2 doi
- 035 __
- $a (PubMed)38163427
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Jacobs, An $u Department of Paediatric Endocrinology and Diabetes, University hospital Leuven, Leuven, Belgium
- 245 10
- $a Pigmented Hypertrichosis with Insulin-Dependent Diabetes Mellitus Syndrome: A Case Series / $c A. Jacobs, P. Cifelli, D. Delbeck, N. Elbarbary, E. Gevers, Z. Sumnik, SA. Amaratunga, A. Pundziute Lyckå, K. Casteels, SWEET and DPV study group
- 520 9_
- $a INTRODUCTION: Pigmented hypertrichosis with insulin-dependent diabetes mellitus (PHID) syndrome is a rare disease, and part of the cluster histiocytosis-lymphadenopathy plus syndrome (H syndrome), which is associated with mutations in the SLC29A3 gene. Patients with PHID show clinical features of H syndrome but also have insulin-dependent diabetes mellitus. The PHID has previously been described as predominantly in absence of pancreatic autoantibodies. Case Series Presentation: Through an open call in two international diabetes registers, clinical and genetic characteristics of 7 PHID patients in 6 treatment centres were collected after informed consent. All of them had consanguinity in their families, and their origins were located in North-African and Middle Eastern regions. Four out of 7 patients had at least one positive pancreatic autoantibody. DISCUSSION AND CONCLUSION: Our case series reveals that PHID exhibits a wide range of clinical symptoms and signs. When consanguinity is present in a patient with newly diagnosed diabetes, and/or if other atypical symptoms such as dysmorphic features, skin lesions, haematological abnormalities, and developmental delay are present, threshold for genetic analysis should be low. Moreover, the presence of autoantibodies should not withhold genetic testing as our case series contradicts the previous observation of predominant autoantibody absence in PHID.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a hypertrichóza $x genetika $7 D006983
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a diabetes mellitus 1. typu $x genetika $x komplikace $7 D003922
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a proteiny přenášející nukleosidy $x genetika $7 D033703
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a pokrevní příbuzenství $7 D003241
- 650 _2
- $a autoprotilátky $x krev $x imunologie $7 D001323
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a syndrom $7 D013577
- 650 _2
- $a kojenec $7 D007223
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Cifelli, Paramita $u Department for Paediatrics, Whipps Cross Hospital, Barts Health NHS Trust, London, UK
- 700 1_
- $a Delbeck, Daniel $u Department of Paediatrics, Helios Klinikum Krefeld, Krefeld, Germany
- 700 1_
- $a Elbarbary, Nancy $u Department of Pediatrics, Diabetes and Endocrinology Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt
- 700 1_
- $a Gevers, Evelien $u Centre for Endocrinology, Queen Mary University of London, London, UK $u Department for Paediatric Endocrinology, Royal London Children's Hospital, Barts Health NHS Trust, London, UK
- 700 1_
- $a Sumnik, Zdenek $u Department of Paediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czechia
- 700 1_
- $a Amaratunga, Shenali Anne $u Department of Paediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czechia
- 700 1_
- $a Pundziute Lyckå, Auste $u Department of Paediatrics, Institute for Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden $u Sahlgrenska University Hospital, Queen Silvia Children's Hospital, Department of Paediatrics, Gothenburg, Sweden
- 700 1_
- $a Casteels, Kristina $u Department of Paediatric Endocrinology and Diabetes, University hospital Leuven, Leuven, Belgium $u Department of Development and Regeneration, KU Leuven, Leuven, Belgium
- 710 2_
- $a SWEET and DPV study group
- 773 0_
- $w MED00175757 $t Hormone research in paediatrics $x 1663-2826 $g Roč. 98, č. 1 (2025), s. 84-88
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38163427 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429135157 $b ABA008
- 999 __
- $a ok $b bmc $g 2311733 $s 1247618
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 98 $c 1 $d 84-88 $e 20240101 $i 1663-2826 $m Hormone research in paediatrics $n Horm Res Paediatr $x MED00175757
- LZP __
- $a Pubmed-20250415